Connect Biopharmaceuticals is Drug Discovery in China that focus on Biopharma Holdings Ltd business. Founded in 2012. They cover business area such as Connect Biopharma Holdings Ltd, development, next-generation immune modulator, serious autoimmune disease, inflammation, its expertise, a portfolio, drug candidate, small molecule, critical pathway, its pipeline.
2012
( 14 years old in 2026 )
Biopharma Holdings Ltd
-
3rd Floor, East R&D Building, Science and Technology Park
6 Beijing West Road
Taicang, Jiangsu 214500
China
Private
Connect Biopharma Holdings Ltddevelopmentnext-generation immune modulatorserious autoimmune diseaseinflammationits expertisea portfoliodrug candidatesmall moleculecritical pathwayits pipeline
* We use standard office opening hours in near Connect Biopharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Connect Biopharmaceuticals is Drug Discovery business from China that founded in 2012 (14 years old in 2026), Connect Biopharmaceuticals business is focusing on Biopharma Holdings Ltd.
Connect Biopharmaceuticals headquarter office and corporate office address is located in 3rd Floor, East R&D Building, Science and Technology Park 6 Beijing West Road Taicang, Jiangsu 214500 China.
Connect Biopharmaceuticals was founded in China.
In 2026, Connect Biopharmaceuticals is currently focus on Biopharma Holdings Ltd sector.
Above is snippet of Google Trends for "Biopharma Holdings Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Connect Biopharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
